132 related articles for article (PubMed ID: 1333639)
1. Haemorrhagic effect of enoxaparin, a low molecular weight heparin. Comparison with unfractionated heparin in humans.
Bang CJ; Riedel B; Talstad I; Berstad A
Scand J Gastroenterol; 1992 Nov; 27(11):924-8. PubMed ID: 1333639
[TBL] [Abstract][Full Text] [Related]
2. [Low molecular weight heparin versus unfractionated heparin in the treatment of deep venous thrombosis--a meta-analysis].
Nielsen JD; Landorph A
Ugeskr Laeger; 1994 Oct; 156(40):5844-9. PubMed ID: 7985276
[TBL] [Abstract][Full Text] [Related]
3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
4. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL;
Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125
[TBL] [Abstract][Full Text] [Related]
5. A new model to assess the haemorrhagic potential of various heparin preparations.
Berstad A; Bang CJ; Talstad I
Acta Chir Scand Suppl; 1990; 556():62-7. PubMed ID: 1963019
[TBL] [Abstract][Full Text] [Related]
6. Gastric mucosal bleeding after unfractionated and low molecular weight heparin in rats.
Bang CJ; Berstad A; Talstad I
Scand J Gastroenterol; 1990 Apr; 25(4):379-82. PubMed ID: 2159654
[TBL] [Abstract][Full Text] [Related]
7. Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.
Riess H; Koppenhagen K; Tolle A; Kemkes-Matthes B; Gräve M; Patek F; Drexler M; Siemens HJ; Harenberg J; Weidinger G; Brom J; Haas S;
Thromb Haemost; 2003 Aug; 90(2):252-9. PubMed ID: 12888872
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
9. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
[TBL] [Abstract][Full Text] [Related]
10. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].
Nimmerfall K; Mischke R
Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154
[TBL] [Abstract][Full Text] [Related]
11. Risk-adjusted strategies in the prevention of early arterial thrombosis following lower extremity arterial reconstruction: a comparison of unfractionated versus low molecular weight heparin.
Winkler MS; Larena-Avellaneda A; Diener H; Kölbel T; Debus ES
J Cardiovasc Surg (Torino); 2013 Feb; 54(1 Suppl 1):183-92. PubMed ID: 23443603
[TBL] [Abstract][Full Text] [Related]
12. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.
Anastassiades E; Ireland H; Flynn A; Lane DA; Curtis JR
Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506
[TBL] [Abstract][Full Text] [Related]
13. Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions: a meta-analysis.
Kodumuri V; Adigopula S; Singh P; Swaminathan P; Arora R; Khosla S
Am J Ther; 2011 May; 18(3):180-9. PubMed ID: 20027109
[TBL] [Abstract][Full Text] [Related]
14. Interaction between heparin and acetylsalicylic acid on gastric mucosal and skin bleeding in humans.
Bang CJ; Riedel B; Talstad I; Berstad A
Scand J Gastroenterol; 1992 Jun; 27(6):489-94. PubMed ID: 1321488
[TBL] [Abstract][Full Text] [Related]
15. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
van Dongen CJ; van den Belt AG; Prins MH; Lensing AW
Cochrane Database Syst Rev; 2004 Oct; (4):CD001100. PubMed ID: 15495007
[TBL] [Abstract][Full Text] [Related]
16. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Hirsh J; Raschke R
Chest; 2004 Sep; 126(3 Suppl):188S-203S. PubMed ID: 15383472
[TBL] [Abstract][Full Text] [Related]
17. Heparin induces mobilization of osteoprotegerin into the circulation.
Vik A; Brodin E; Sveinbjørnsson B; Hansen JB
Thromb Haemost; 2007 Jul; 98(1):148-54. PubMed ID: 17598007
[TBL] [Abstract][Full Text] [Related]
18. Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover.
Roschitz B; Beitzke A; Gamillscheg A; Sudi K; Koestenberger M; Leschnik B; Muntean W
Thromb Res; 2003; 111(6):335-41. PubMed ID: 14698650
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
[TBL] [Abstract][Full Text] [Related]
20. Randomised controlled trial for efficacy of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in thrombo-prophylaxis.
Ishi SV; Lakshmi M; Kakde ST; Sabnis KC; Jagannati M; Girish TS; Jeyaseelan L; Cherian AM
J Assoc Physicians India; 2013 Dec; 61(12):882-6. PubMed ID: 24968543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]